유방 관상피내암에서 초음파와 MRI의 종양 크기 예측 정확도 비교 = Comparative Accuracy of Preoperative Tumor Size Assessment on Ultrasonography and Magnetic Resonance Imaging in Ductal Carcinoma In Situ

다국어 초록 (Multilingual Abstract)

Purpose: The purpose of this study was to compare the accuracy of preoperative breast tumor size measured by ultrasonography (US) and magnetic resonance imaging (MRI) in patients with ductal carcinoma in situ (DCIS). Methods: Medical records of 74 patients postoperatively diagnosed with DCIS were retrospectively analyzed. Tumor size measurements obtained using the two imaging modalities were compared for accuracy with those obtained during the final pathologic examination. Patients with only microcalcification on imaging were excluded. Results: For all patients, Lin’s concordance correlation coefficient (CCC) of MRI was 0.725, which was more accurate than 0.670 of US. In subgroup analysis, CCC of US was 0.757, more accurate than 0.697 of MRI in premenopausal DCIS patients. Background parenchymal enhancement (BPE) was the only risk factor deteriorating the accuracy of US and MRI examinations. Moderate and marked BPE was associated with the inaccurate tumor size estimations in both US and MRI (odds ratio [OR]:2.23, 95% confidence interval [CI]=1.12−3.52, p=0.001 in US, OR:8.16, 95% CI=1.17−15.2, p=0.031 in MRI). Conclusion: MRI was more accurate for measuring tumor size in patients with DCIS. Moderate and marked BPE was a risk factor that prevented accurate measurement of preoperative tumor size. In premenopausal patients, US would help measure tumor size accurately.

참고문헌 (Reference)

1 김은혁, "조기 유방암에서 수술 전 유방초음파 및 유방 자기공명영상검사와 수술 후 병리학적 종양 크기에 대한 비교 연구" 한국유방암학회 8 (8): 19-24, 2020

2 Breen N, "Update on mammography trends : comparisons of rates in 2000, 2005, and 2008" 117 : 2209-2218, 2011

3 "The Asia-Pacific perspective: redefining obesity and its treatment" World Health Organization

4 Yeh E, "Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer" 184 : 868-877, 2005

5 Fitzgibbons PL, "Prognostic factors in breast cancer. College of American Pathologists consensus statement 1999" 124 : 966-978, 2000

6 Musaed Rayzah, "Preoperative Breast Magnetic Resonance Imaging for the Assessment of the Size of Ductal Carcinoma In Situ" 한국유방암학회 4 (4): 77-84, 2016

7 Houvenaeghel G, "Positive or close margins: reoperation rate and second conservative resection or total mastectomy?" 11 : 2507-2516, 2019

8 Gruber IV, "Measurement of tumour size with mammography, sonography and magnetic resonance imaging as compared to histological tumour size in primary breast cancer" 13 : 328-, 2013

9 Byrne C, "Mammographic features and breast cancer risk : effects with time, age, and menopause status" 87 : 1622-1629, 1995

10 Hata T, "Magnetic resonance imaging for preoperative evaluation of breast cancer : a comparative study with mammography and ultrasonography" 198 : 190-197, 2004

11 Vincent-Salomon A, "Integrated genomic and transcriptomic analysis of ductal carcinoma in situ of the breast" 14 : 1956-1965, 2008

12 "Ductal carcinoma in situ: terminology, classification, and natural history" Oxford academic

13 Behjatnia B, "Does size matter? Comparison study between MRI, gross, and microscopic tumor sizes in breast cancer in lumpectomy specimens" 3 : 303-309, 2010

14 Lai HW, "Comparison of the diagnostic accuracy of magnetic resonance imaging with sonography in the prediction of breast cancer tumor size : a concordance analysis with histopathologically determined tumor size" 22 : 3816-3823, 2015

15 Leddy R, "Comparative accuracy of preoperative tumor size assessment on mammography, sonography, and MRI: is the accuracy affected by breast density or cancer subtype?" 44 : 17-25, 2016

16 Min-Ji Park, "Clinical Significance of Non-Mass-Like Enhancement of Preoperative Magnetic Resonance Imaging in Breast Cancer Considering Breast-Conserving Surgery" 한국유방암학회 6 (6): 20-24, 2018

17 Ramirez SI, "Breast cancer tumor size assessment with mammography, ultrasonography, and magnetic resonance imaging at a community based multidisciplinary breast center" 78 : 440-446, 2012

18 DeSantis CE, "Breast cancer statistics, 2019" 69 : 438-451, 2019

19 강상율, "Breast Cancer Statistics in Korea, 2018" 한국유방암학회 24 (24): 123-137, 2021

20 강상율, "Breast Cancer Statistics in Korea in 2017: Data from a Breast Cancer Registry" 한국유방암학회 23 (23): 115-128, 2020

21 DeMartini WB, "Background parenchymal enhancement on breast MRI : impact on diagnostic performance" 198 : W373-80, 2012

22 Liao GJ, "Background parenchymal enhancement on breast MRI : a comprehensive review" 51 : 43-61, 2020

23 Uematsu T, "Background enhancement of mammary glandular tissue on breast dynamic MRI : imaging features and effect on assessment of breast cancer extent" 19 : 259-265, 2012

24 Wadsten C, "A validation of DCIS registration in a population-based breast cancer quality register and a study of treatment and prognosis for DCIS during 20 years : two decades of DCIS in Sweden" 66 : 1338-1343, 2016